Regeneron looks to George Yancopoulos' R&D arm — and partners — in hunt for its next big cash cows

John Carroll

Editor & Founder

Regeneron R&D chief and co-founder George Yancopoulos has never been shy about touting the company’s research capabilities — or ambitions. But then, he’s also a standout …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Regeneron looks to George Yancopoulos' R&D arm — and partners — in hunt for its next big cash cows

John Carroll

Editor & Founder

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Where the money is: The top 100 venture investors in biotech

J&J seeks to stop Samsung Bioepis from licensing Stelara biosimilar

Lilly pays $10M upfront for Organovo’s FXR agonist program

Compounders sue FDA over removal of semaglutide from official shortage list

Candel's viral therapy shows promising survival in small pancreatic cancer study

How AI can address ongoing challenges in the life sciences industry

Re­gen­eron looks to George Yan­copoulos' R&D arm — and part­ners — in hunt for its next big cash cows

Editor & Founder

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Regeneron looks to George Yancopoulos' R&D arm — and partners — in hunt for its next big cash cows